Vaxart continued its strong late June move, up over 18% today. NantKwest (NK) was up 13.5% and Vir Biotechnology was up just under 13%. Generex Biotechnology (GNBT) moved up over 10%.
Inovio's press release on the results of a preliminary clinical trial did not overly impress as it was the weakest of the COVID VACCINE Stocks, falling just under 15%. GeoVax gave up half of its 29% gain from yesterday and iBio fell 11%.
Overall, these stocks turned in another positive day with 14 stocks up and 11 down. The average COVID VACCINE Stock gained about 1.6% for the quietest day we've seen in awhile.
No comments:
Post a Comment